Injectable Birth Control Increases HIV Risk by 40%

This article summarizes evidence from the Hapgood study concluding that women using the injectable progestin contraceptive depot medroxyprogesterone acetate, or DMPA, may face a substantially elevated risk for HIV infection compared with other forms of hormonal birth control, according to a research review.